CTT Pharmaceutical Cash Flow From Operations vs. Beta
| CTTH Stock | USD 0.07 0 2.29% |
For CTT Pharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CTT Pharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CTT Pharmaceutical Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CTT Pharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CTT Pharmaceutical Holdings over time as well as its relative position and ranking within its peers.
CTT |
CTT Pharmaceutical Beta vs. Cash Flow From Operations Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining CTT Pharmaceutical's current stock value. Our valuation model uses many indicators to compare CTT Pharmaceutical value to that of its competitors to determine the firm's financial worth. CTT Pharmaceutical Holdings is number one stock in cash flow from operations category among its peers. It also is number one stock in beta category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value CTT Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CTT Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.CTT Beta vs. Cash Flow From Operations
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
CTT Pharmaceutical |
| = | (145.16 K) |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
CTT Pharmaceutical |
| = | 1.14 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
CTT Beta Comparison
CTT Pharmaceutical is currently under evaluation in beta category among its peers.
Beta Analysis
CTT Pharmaceutical returns are very sensitive to returns on the market. As the market goes up or down, CTT Pharmaceutical is expected to follow.
CTT Pharmaceutical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in CTT Pharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CTT Pharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of CTT Pharmaceutical's change in net profit over the period of time. It can combine multiple indicators of CTT Pharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. Ctt Pharmaceutical is traded on OTC Exchange in the United States.
CTT Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on CTT Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CTT Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CTT Pharmaceutical's important profitability drivers and their relationship over time.
Use CTT Pharmaceutical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CTT Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CTT Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.CTT Pharmaceutical Pair Trading
CTT Pharmaceutical Holdings Pair Trading Analysis
The ability to find closely correlated positions to CTT Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CTT Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CTT Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CTT Pharmaceutical Holdings to buy it.
The correlation of CTT Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CTT Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CTT Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CTT Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your CTT Pharmaceutical position
In addition to having CTT Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Commodities ETFs Thematic Idea Now
Broad Commodities ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Commodities ETFs theme has 26 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Commodities ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in CTT Pink Sheet
To fully project CTT Pharmaceutical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of CTT Pharmaceutical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include CTT Pharmaceutical's income statement, its balance sheet, and the statement of cash flows.